Reaction

Pneumonia Staphylococcal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,945 reports · 71 co-occurring drugs

As of the last recalculation, Pneumonia Staphylococcal appears in 1,945 FAERS reports alongside 71 co-occurring drug terms. The strongest observed disproportionality signal is REMDESIVIR (PRR 31.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Remdesivir	39	31.9	32.0
Phytonadione	19	24.2	24.2
Thiotepa	21	23.8	23.8
Anti-Thymocyte Globulin (Rabbit)	16	21.4	21.4
Baricitinib	19	21.3	21.3
Lumacaftor And Ivacaftor	16	20.1	20.2
Vancomycin	89	17.2	17.2
Linezolid	46	16.9	16.9
Vancomycin Hydrochloride	98	16.7	16.7
Cefepime Hydrochloride	23	15.4	15.5
Tobramycin	34	15.4	15.4
Dornase Alfa	27	14.9	14.9
Piperacillin Sodium And Tazobactam Sodium	27	14.9	14.9
Busulfan	21	14.4	14.4
Cefepime	19	14.3	14.3
Tobramycin Solution	14	12.6	12.6
Fludarabine Phosphate	45	12.5	12.5
Tobramycin Sulfate	14	12.2	12.2
Ceftriaxone Sodium	39	11.1	11.1
Ursodiol	22	10.9	10.9
Cefazolin Sodium	12	10.7	10.7
Mesna Injection	8	10.4	10.4
Amphetamine	8	10.4	10.4
Insulin Glargine-Yfgn	21	10.4	10.4
Ceftriaxone	31	10.3	10.3
Mesna	8	10.2	10.2
Ganciclovir Sodium	10	10.2	10.2
Micafungin Sodium	8	10.1	10.1
Magnesium Sulfate In Water For	12	10.1	10.1
Basiliximab	11	10.1	10.1
Polyethylene Glycol	10	9.9	9.9
Magnesium Sulfate Heptahydrate	12	9.9	9.9
Magnesium Sulfate	12	9.9	9.9
Voriconazole Injection	19	9.4	9.5
Ipratropium Bromide	31	9.4	9.4
Cefazolin	8	9.4	9.4
Tacrolimus	129	9.4	9.4
Atovaquone	7	9.3	9.3
Norepinephrine	9	9.0	9.1
Sirolimus	11	8.8	8.8
Tacrolimus Ointment 0.1%	96	8.6	8.6
Tacrolimus Extended-Release Capsules	96	8.6	8.6
Ganciclovir	8	8.4	8.4
Ursosiol	15	8.3	8.3
Propofol	28	8.3	8.3
Norepinephrine Bitartrate	11	8.2	8.2
Voriconazole	23	8.2	8.2
Epoetin Alfa	9	8.2	8.2
Midazolam	19	8.1	8.1
Midazolam Hydrochloride	20	8.0	8.0
Piperacillin And Tazobactam	9	7.6	7.6
Pancrelipase	26	7.3	7.3
Oxazepam	14	7.0	7.0
Tramadol Hydrochloride	24	6.9	6.9
Guaifenesin	18	6.4	6.4
Daratumumab	23	6.2	6.2
Fentanyl Citrate	10	6.0	6.0
Temozolomide	11	5.6	5.6
Ivacaftor	4	5.4	5.4
Elexacaftor, Tezacaftor, And Ivacaftor	6	5.2	5.2
Deferasirox	12	4.9	4.9
Bortezomib	40	4.9	4.9
Daptomycin	4	4.6	4.6
Panitumumab	6	4.1	4.1
Bosentan	19	4.1	4.1
Sofosbuvir	7	3.8	3.8
Benralizumab	7	3.8	3.8
Axicabtagene Ciloleucel	3	3.3	3.3
Peginterferon Alfa-2A	16	3.2	3.2
Ixazomib	8	3.0	3.0
Pomalidomide	21	2.2	2.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.